Healthy Aging Health Center
Boomers Doomed to Disability?
Nov. 12, 2009 -- Baby boomers are entering their 60s just in time for a new trend: disability.
One in five 60-somethings need help with basic daily activities -- up from 13% just a decade ago. Various disabilities are up 40% to 70% in 60- to 69-year-olds, UCLA researcher Teresa E. Seeman, PhD, and colleagues find.
Seeman's team analyzed federal disability data collected from people over age 60 in 1988-1994 and in 1999-2004. The most recent data therefore captures only a few of those born during the baby boom of 1946-1964.
But the trends bode ill for boomers.
"Our results have significant and sobering implications," Seeman and colleagues say. "To the extent that persons currently aged 60 to 69 years are harbingers of likely disability trends for the massive baby-boomer generation, the health care and assistance needs of disabled older Americans could, in the not so distant future, impose heavy burdens on families and society."
Compared with those surveyed in 1988-1994, 60-somethings surveyed in 1999-2004 were:
- 70% more likely to have difficulty walking from room to room, getting in and out of bed, and/or eating and dressing.
- 70% more likely to have difficulty doing chores, preparing meals, and/or managing money
- 50% more likely to have difficulty walking a quarter mile and/or walking up 10 steps without rest
- 40% more likely to have difficulty stooping, crouching, or kneeling; lifting or carrying 10 pounds; and/or standing from an armless chair.
Not surprisingly, given the ongoing obesity epidemic, people who entered their 60s from 1999 to 2004 were much more likely to be obese, to have a too-large waist size, and to get less exercise than those who turned 60 from 1988-1994.
Disability was significantly more likely among obese or overweight 60-somethings and among African-Americans and Hispanic-Americans. But neither health status, health behavior, race, or ethnicity -- taken separately or together -- fully explained the trend toward more disability.
Seeman and colleagues report their findings in the American Journal of Public Health, published online ahead of print on Nov. 12.
VIVELLE-DOT (estradiol transdermal system) IS AVAILABLE BY PRESCRIPTION ONLY.
INDICATION
Vivelle-Dot is used after menopause to: reduce moderate to severe hot flashes; treat moderate to severe dryness, itching and burning in or around the vagina; help reduce your chances of getting osteoporosis (thin weak bones); and treat certain conditions in which a young woman's ovaries do not produce enough estrogens naturally. Vivelle-Dot 0.025 mg/day is only used to prevent osteoporosis from menopause. If you use Vivelle-Dot only to treat your dryness, itching, and burning in and around your vagina or if you use Vivelle-Dot only to prevent osteoporosis from menopause, talk with your healthcare professional about whether a different treatment or medicine without estrogens might be better for you.
IMPORTANT SAFETY INFORMATION
Estrogens increase the chances of getting cancer of the uterus (womb). Report any unusual vaginal bleeding right away while you are taking estrogens. Vaginal bleeding after menopause may be a warning sign of cancer of the uterus (womb).
Do not use estrogens with or without progestins to prevent heart disease, heart attacks, or strokes. Using estrogens with or without progestins may increase your chances of getting heart attacks, strokes, breast cancer, and blood clots. Using estrogens with progestins may increase your risk of dementia (decline in memory and thinking skills).
Vivelle-Dot should not be used if you have unusual vaginal bleeding; currently have or have had certain cancers, including cancer of the breast or uterus; had a stroke or heart attack in the recent past (for example, in the past year); currently have or have had blood clots; currently have or have had liver problems; or think you may be, or know that you are, pregnant.
The most common side effects that may occur with Vivelle-Dot are headache, breast tenderness, and back pain.
You and your healthcare professional should talk regularly about whether you still need treatment with Vivelle-Dot.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Please see Full Prescribing Information for Vivelle-Dot.


